Josh Cohen
Patrimonio netto: 105 M $ in data 30/09/2026
Patrimonio netto: 105 M $ in data 30/09/2026
Mr. Joshua B. Cohen is an Independent Director at TCGX Acquisition Corp.
II and a Co-Chief Executive Officer & Director at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at TCGX Acquisition Corp.
II, Amylyx Pharmaceuticals, Inc. and Practice XYZ LLC.
Mr. Cohen was previously employed as a Founder by Brown Biotechnology Investment Group.
He received his undergraduate degree from Brown University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/09/2026 | 3.613.123 ( 3,27% ) | 105 M $ | 30/09/2026 | |
1,2% | 19/10/2026 | 30.000 ( 1,2% ) | 325 800 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Fondatore | 01/01/2013 |
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Brown Biotechnology Investment Group | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Technology Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Brown Biotechnology Investment Group |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale